Thermo Fisher Scientific Palivizumab Polyclonal Antibody
Rabbit polyclonal antibody against Palivizumab for ELISA applications. Recognizes human RSV F protein target. Lyophilized form, reconstitutable to 0.5 mg/mL. Suitable for research use only.
- 카탈로그번호
- A0206440
- 판매단위
- pk
카탈로그
1개 옵션 · 카탈로그 번호를 클릭하면 복사됩니다Thermo Fisher Scientific · Thermo Fisher Scientific Palivizumab Polyclonal Antibody
Applications
- ELISA (ELISA)
Tested Dilution: 0.05–1 µg/mL
Product Specifications
| 항목 | 내용 |
|---|---|
| Species Reactivity | Human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen | Palivizumab |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Purification | Antigen affinity chromatography |
| Storage Buffer | PBS, pH 7.4 |
| Contains | 0.02% sodium azide |
| Storage Conditions | -20°C or -80°C if preferred |
| Shipping Conditions | Ambient (domestic); Wet ice (international) |
Product Specific Information
Reconstitute the lyophilized antibody with deionized water (or equivalent) to a final concentration of 0.5 mg/mL.
Palivizumab (trade name Synagis) is an FDA-approved drug for the prevention of respiratory syncytial virus (RSV) infections. It is a recombinant humanized IgG1 kappa isotype monoclonal antibody. Palivizumab binds the RSV envelope fusion protein (RSV F) on the surface of the virus, blocking a critical step in the membrane fusion process.
GenScript Anti-Palivizumab Antibody, pAb, Rabbit is produced from sera of a rabbit immunized with Palivizumab.
Target Information
Palivizumab (Synagis) is an FDA-approved drug for the prevention of RSV infections. It is a recombinant humanized IgG1 kappa monoclonal antibody that binds the RSV envelope fusion protein (RSV F), inhibiting the membrane fusion process.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Thermo Fisher Scientific 상품 둘러보기
전체보기
문의
0개 · 배송·재고 문의는 실시간 상담이 빠릅니다아직 등록된 문의가 없어요.